Passa al contenutoPassa al piè di pagina
      employer cover photo
      employer logo
      employer logo

      Standard BioTools

      Questa è la tua azienda?

      Recensioni su Standard BioTools

      Exceptionally talented team in Europe - Recensione dipendente - Dipendente anonimo presso Standard BioTools

      5,0
      1 feb 2019
      Dipendente anonimo
      Consiglia
      Gradimento del CEO
      Pronostico commerciale

      Vantaggi

      I recently joined the Fluidigm team in EMEA and have had a fantastic experience including: - a thorough interview and onboarding process - a one and a half day comprehensive induction - travel across Europe meeting all key stakeholders - exceptionally friendly and welcoming colleagues and a leadership team who engage with you from day 1 - highly qualified team with deep expertise in their field - excellent salary and benefits package - flexible working environment - rapid growth - 'Life Sciences Industry Awards Company to Watch 2019'

      Svantaggi

      The pace of change is intense but the leadership team is bringing people with them and supporting them to achieve their potential

      Esplora altre recensioni su Standard BioTools

      5,0
      2 apr 2025
      Dipendente anonimo
      Consiglia
      Gradimento del CEO
      Pronostico commerciale

      Vantaggi

      Hard working employees and managers that go to bat for their employees

      Svantaggi

      Lack of help in marketing

      1,0
      12 apr 2026
      Regional sales manager
      Consiglia
      Gradimento del CEO
      Pronostico commerciale

      Vantaggi

      Unique Technology & Recently updated. Very good for specific applications and research. Respectable pay and benefits if you don't get RIF'd after your first few months on the job. Technology is as unique as a 3 dollar bill.

      Svantaggi

      Company reduces workforce about every year & is owned by private equity (i.e. - Very unstable/based only on quarterly profits & not individual contributions). High Turnover so DO NOT expect a long career here. Solutions are not valuable to a majority of institutions. The majority of the target market has abandoned the technology due to poor prior experiences and will not reconsider it.

      1
      Vedi recensioni per: Utile|Valutazione|Data|Tutto
      Ricerche correlate: Offerte di lavoro di Standard BioTools | Stipendi di Standard BioTools | Benefit di Standard BioTools | Colloqui di Standard BioTools
      Recensioni su Standard BioToolsRecensioni su Standard BioTools, CambridgeRecensione su Standard BioTools